Huawei named one of Thomson Reuters’ ‘Top 100 Global Innovators of 2014’
Thursday, 13 November 2014 00:00
-
- {{hitsCtrl.values.hits}}
Huawei said yesterday it has been named to Thomson Reuters’ ‘Top 100 Global Innovators of 2014’ list.
Huawei is notably the only mainland Chinese company to make the ranking, started in 2011,which focuses on global leadership in innovation across industries assessing factors including a company’s overall patent volume, patent grant success rate, global reach of patent portfolio, and patent influence as evidenced by citations by other companies.
With 7,000 invention patents and 1,000 design patent applications filed by Huawei’s Consumer Business Group alone through August 2014, the company’s active investments in R&D have paid off with successful flagship products like the recently released Huawei Mate7 and Huawei P7.
The Mate7 has received industry acclaim for its precise single-touch fingerprint technology, utilising 508PPI ratio reader, which enables users to unlock the phone at least 80% faster than devices using sweeping recognition options. Among its standout features, the P7 has been noted for its camera technology, in particular an innovative 8MP 5P non-spherical lens front-facing camera equipped with panorama function for panoramic “selfie” shooting.
“At Huawei, one of our key success driversin expanding globally has been a dedicated commitment to R&D and ongoing patent innovation. This recognition from Thomson Reuters is testament to that commitment,” said Shao Yang, Vice President of Marketing, Huawei Consumer Business Group.
“With the results of our investment bearing successful products like the flagship Mate7 and P7, which have been popularly received in global markets, we look forward to continuing to create breakthroughs and making it possible for our fans around the world.”
On a company-wide level, through June 2014, Huawei Technologies had filed more than 65,000 patent applications in China, the US, and Europe. Annually, Huawei Technologies invests approximately 10% of its R&D investment in innovation research.
